CONAGRA BRANDS INC. (CAG): debt financing — Conagra Brands refinances $2B revolving credit facility, extends maturity to 2030

CONAGRA BRANDS INC.

New $2.0B revolving credit facility matures June 27, 2030, replacing $2.0B facility set to mature Aug 2027.
Interest rate based on Term SOFR plus spread from 0.805% to 1.30% depending on debt ratings.
Facility is unsecured; covenants include max net leverage and min interest coverage ratios.
No borrowings were outstanding under prior facility on closing date June 27, 2025.
Extension option: Company may extend maturity for additional 1 or 2 years annually.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

CONAGRA BRANDS INC. incurred revolving credit of $2.0 billion with Bank of America, N.A. at Term SOFR, plus a percentage spread (ranging from 0.805% per annum to 1.30% per maturing June 27, 2030.

Instrument: revolving credit
Principal: $2.0 billion
Counterparty: Bank of America, N.A.
Rate: Term SOFR, plus a percentage spread (ranging from 0.805% per annum to 1.30% per
Maturity: June 27, 2030
Event: incurrence

Exact text from the filing

On June 27, 2025 (the “Closing Date”), Conagra Brands, Inc. (the “Company”) entered into a Third Amended and Restated Revolving Credit Agreement (the “Revolving Credit Agreement”) with Bank of America, N.A. (“Bank of America”), as administrative agent and a lender, and the other lenders party thereto, providing for a revolving credit facility in a maximum aggregate principal amount outstanding at any one time of $2.0 billion.

View on SEC.gov

114 debt financings filed in the last 30 days. Browse all debt financings →

CONAGRA BRANDS INC. filing history →

Source: SEC EDGAR

accession 0000023217-25-000035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.